Rs 107 10 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
Volibo 0.2 mg Tablets are designed to provide relief from symptoms associated with vestibular disorders, including Meniere's disease. Each tablet contains 0.2 mg of Betahistine dihydrochloride, a medication known for its effectiveness in improving blood circulation within the inner ear. This enhanced blood flow helps to stabilize inner ear pressure, which can alleviate symptoms such as dizziness, vertigo, and tinnitus. The tablets are formulated for convenience, with an easy-to-swallow design that ensures precise dosing. Packaged in a 10-tablet bottle, Volibo 0.2 mg offers a practical solution for managing symptoms both in the short term and as part of an ongoing treatment regimen. By addressing the underlying causes of vestibular symptoms, Volibo helps improve overall quality of life for individuals experiencing these conditions.
Active Ingredient: Contains 0.2 mg of Betahistine dihydrochloride. Symptom Relief: Primarily used for managing symptoms related to vestibular disorders such as dizziness, vertigo, and tinnitus. Improves Inner Ear Circulation: Betahistine enhances blood flow to the inner ear, helping to stabilize inner ear pressure and alleviate symptoms. Convenient Tablet Form: Available in an easy-to-swallow tablet format, ensuring accurate dosing and ease of administration. 10-Tablet Pack: Supplied in a pack of 10 tablets, suitable for both short-term relief and as part of a longer-term treatment plan.
VOLIBO 0.2MG TABLET functions by inhibiting intestinal enzymes that break down complex sugars into simple sugars like glucose. This helps prevent a rapid spike in blood glucose levels immediately after meals.
Take VOLIBO 0.2MG TABLET as directed by your physician. Your doctor will determine the appropriate dose and duration based on your age, body weight, and medical condition. Continue taking VOLIBO 0.2MG TABLET for the prescribed duration to achieve optimal results. For Tablets: Swallow VOLIBO 0.2MG TABLET with a glass of water. Do not crush or chew the tablet. For Dispersible Tablets: Dissolve VOLIBO 0.2MG TABLET in the amount of water specified on the label or as instructed by your doctor. Drink the mixture immediately after preparation.
PREGNANCY RISKY: VOLIBO 0.2MG TABLET should be used during pregnancy only if the potential benefits outweigh the risks to the fetus. Consult your doctor before using this medication. BREASTFEEDING CONTRAINDICATED: VOLIBO 0.2MG TABLET is generally not recommended for breastfeeding women as it may pass into breast milk. Consult your doctor before using this medication. KIDNEY USE WITH CAUTION: VOLIBO 0.2MG TABLET should be used with caution in patients with kidney issues. Consult your doctor for advice. LIVER USE WITH CAUTION: VOLIBO 0.2MG TABLET should be used with caution in patients with liver issues. Consult your doctor for advice. ALLERGY CONTRAINDICATED: Do not use VOLIBO 0.2MG TABLET if you are allergic to Voglibose or any other ingredients in this medicine. USE IN PEDIATRICS CONSULT YOUR DOCTOR: The safety of VOLIBO 0.2MG TABLET in children has not been established. Consult your doctor before using this medication in pediatric patients. USE IN GERIATRICS USE WITH CAUTION: VOLIBO 0.2MG TABLET should be used with caution in elderly patients. Consult your doctor before using this medication.
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s